Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced that it has entered into a definitive agreement to acquire Robocath, a venture-backed innovator of robotic technologies for interventional...
Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced that it has entered into a definitive agreement to...
International medical imaging IT and cybersecurity company Sectra has completed the acquisition of Oxipit, a pioneer in autonomous AI for radiology and the developer...
Sonire Therapeutics has raised $18m towards supporting the ongoing clinical advancement of its non-invasive thermal ablation tumour treatment system.
The Tokyo, Japan-headquartered company’s Series A...
Calyxo announced that it closed a Series F financing round worth $40 million.
Ally Bridge Group and Janus Henderson Investors led the financing. Questa Capital,...
FeelTect has kicked off a clinical trial in Ireland to evaluate its wearable, pressure-sensing device for vein ulcers.
Researchers at the University of Galway will...
Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system.
Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...
iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...
Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease.
The...
Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, announced that it has entered into a definitive agreement to...
International medical imaging IT and cybersecurity company Sectra has completed the acquisition of Oxipit, a pioneer in autonomous AI for radiology and the developer...
Sonire Therapeutics has raised $18m towards supporting the ongoing clinical advancement of its non-invasive thermal ablation tumour treatment system.
The Tokyo, Japan-headquartered company’s Series A...
Calyxo announced that it closed a Series F financing round worth $40 million.
Ally Bridge Group and Janus Henderson Investors led the financing. Questa Capital,...